De Novo prion aggregates trigger autophagy in skeletal muscle

Journal of Virology

Volumn 88, Issue 4, 2014, Pages 2071-2082

  Joshi Barr, Shivanjali ^a   Bett, Cyrus ^a   Chiang, Wei Chieh ^a   Trejo, Margarita ^b   Goebel, Hans H ^c   Sikorska, Beata ^d   Liberski, Pawel ^d   Raeber, Alex ^e   Lin, Jonathan H ^a   Masliah, Eliezer ^b   Sigurdsona, Christina J ^a,f  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^d MEDICAL UNIVERSITY OF LODZ   (Poland)

^e Prionics AG   (Switzerland)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALS; AUTOPHAGY; BLOTTING, WESTERN; DNA PRIMERS; HEAT-SHOCK PROTEINS; IMMUNOHISTOCHEMISTRY; MICE; MICE, TRANSGENIC; MUSCLE CELLS; MUSCLE, SKELETAL; POLYMERASE CHAIN REACTION; PRION DISEASES;

EID: 84893472608     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02279-13     Document Type: Article

References (73)

1. Prusiner SB. 1982. Novel proteinaceous infectious particles cause scrapie. Science 216:136-144. http://dx.doi.org/10.1126/science.6801762.
2. Prusiner SB. 1984. Prions: novel infectious pathogens. Adv. Virus Res. 29:1-56. http://dx.doi.org/10.1016/S0065-3527(08)60404-2.
3. Wadsworth JD, Collinge J. 2011. Molecular pathology of human prion disease. Acta Neuropathol. 121:69-77. http://dx.doi.org/10.1007/s00401-010-0735-5.
4. Aguzzi A, Falsig J. 2012. Prion propagation, toxicity and degradation. Nat. Neurosci. 15:936-939. http://dx.doi.org/10.1038/nn.3120.
5. Deleault NR, Harris BT, Rees JR, Supattapone S. 2007. Formation of native prions from minimal components in vitro. Proc. Natl. Acad. Sci.U.S.A. 104:9741-9746. http://dx.doi.org/10.1073/pnas.0702662104.
6. Wang F, Wang X, Yuan CG, Ma J. 2010. Generating a prion with bacterially expressed recombinant prion protein. Science 327:1132-1135.http://dx.doi.org/10.1126/science.1183748.
7. Makarava N, Kovacs GG, Bocharova O, Savtchenko R, Alexeeva I, Budka H, Rohwer RG, Baskakov IV. 2010. Recombinant prion protein induces a new transmissible prion disease in wild-type animals. Acta Neuropathol.119:177-187. http://dx.doi.org/10.1007/s00401-009-0633-x.
8. Hilbe MM, Soldati GG, Zlinszky KK, Wunderlin SS, Ehrensperger FF.2009. Immunohistochemical study of PrPSc distribution in neural and extraneural tissues of two cats with feline spongiform encephalopathy.BMC Vet. Res. 5:11. http://dx.doi.org/10.1186/1746-6148-5-11.
9. Sigurdson CJ, Spraker TR, Miller MW, Oesch B, Hoover EA. 2001. PrPCWD in the myenteric plexus, vagosympathetic trunk and endocrine glands of deer with chronic wasting disease. J. Gen. Virol. 82:2327-2334.http://vir.sgmjournals.org/content/82/10/2327.long.
10. Ironside JW. 2010. Variant Creutzfeldt-Jakob disease. Haemophilia 16(Suppl. 5):175-180. http://dx.doi.org/10.1111/j.1365-2516.2010.02317.x.
11. Herzog C, Riviere J, Lescoutra-Etchegaray N, Charbonnier A, Leblanc V, Sales N, Deslys JP, Lasmezas CI. 2005. PrPTSE distribution in a primate model of variant, sporadic, and iatrogenic Creutzfeldt-Jakob disease.J. Virol. 79:14339-14345. http://dx.doi.org/10.1128/JVI.79.22.14339-14345.2005.
12. Glatzel M, Abela E, Maissen M, Aguzzi A. 2003. Extraneural pathologic prion protein in sporadic Creutzfeldt-Jakob disease. N. Engl. J. Med. 349:1812-1820. http://dx.doi.org/10.1056/NEJMoa030351.
13. Kovacs GG, Lindeck-Pozza E, Chimelli L, Araujo AQ, Gabbai AA, Strobel T, Glatzel M, Aguzzi A, Budka H. 2004. Creutzfeldt-Jakob disease and inclusion body myositis: abundant disease-associated prion protein in muscle. Ann. Neurol. 55:121-125. http://dx.doi.org/10.1002/ana.10813.
14. Thomzig A, Kratzel C, Lenz G, Kruger D, Beekes M. 2003. Widespread PrPSc accumulation in muscles of hamsters orally infected with scrapie.EMBO Rep. 4:1-4. http://dx.doi.org/10.1038/sj.embor.embor717.
15. Andreoletti O, Simon S, Lacroux C, Morel N, Tabouret G, Chabert A, Lugan S, Corbiere F, Ferre P, Foucras G, Laude H, Eychenne F, Grassi J, Schelcher F. 2004. PrPSc accumulation in myocytes from sheep incubating natural scrapie. Nat. Med. 10:591-593. http://dx.doi.org/10.1038/nm1055.
16. Angers RC, Browning SR, Seward TS, Sigurdson CJ, Miller MW, Hoover EA, Telling GC. 2006. Prions in skeletal muscles of deer with chronic wasting disease. Science 311:1117. http://dx.doi.org/10.1126/science.1122864.
17. Westaway D, DeArmond SJ, Cayetano-Canlas J, Groth D, Foster D, Yang SL, Torchia M, Carlson GA, Prusiner SB. 1994. Degeneration of skeletal muscle, peripheral nerves, and the central nervous system in transgenic mice overexpressing wild-type prion proteins. Cell 76:117-129. http://dx.doi.org/10.1016/0092-8674(94)90177-5.
18. Huang S, Liang J, Zheng M, Li X, Wang M, Wang P, Vanegas D, Wu D, Chakraborty B, Hays AP, Chen K, Chen SG, Booth S, Cohen M, Gambetti P, Kong Q. 2007. Inducible overexpression of wild-type prion protein in the muscles leads to a primary myopathy in transgenic mice.Proc. Natl. Acad. Sci. U.S.A. 104:6800-6805. http://dx.doi.org/10.1073/pnas.0608885104.
19. Bosque PJ, Ryou C, Telling G, Peretz D, Legname G, DeArmond SJ, Prusiner SB. 2002. Prions in skeletal muscle. Proc. Natl. Acad. Sci. U.S.A. 99:3812-3817. http://dx.doi.org/10.1073/pnas.052707499.
20. Riek R, Hornemann S, Wider G, Billeter M, Glockshuber R, Wüthrich K. 1996. NMR structure of the mouse prion protein domain PrP (121-231). Nature 382:180-182. http://dx.doi.org/10.1038/382180a0.
21. Sigurdson CJ, Nilsson KP, Hornemann S, Heikenwalder M, Manco G, Schwarz P, Ott D, Rulicke T, Liberski PP, Julius C, Falsig J, Stitz L, Wüthrich K, Aguzzi A. 2009. De novo generation of a transmissible spongiform encephalopathy by mouse transgenesis. Proc. Natl. Acad. Sci. U.S.A. 106:304-309. http://dx.doi.org/10.1073/pnas.0810680105.
22. Hershko A, Ciechanover A. 1998. The ubiquitin system. Annu. Rev. Biochem. 67:425-479. http://dx.doi.org/10.1146/annurev.biochem.67.1.425.
23. Ciechanover A. 2012. Intracellular protein degradation: from a vague idea thru the lysosome and the ubiquitin-proteasome system and onto human diseases and drug targeting. Biochim. Biophys. Acta 1824:3-13. http://dx.doi.org/10.1016/j.bbapap.2011.03.007.
24. Wong E, Cuervo AM. 2010. Autophagy gone awry in neurodegenerative diseases. Nat. Neurosci. 13:805-811. http://dx.doi.org/10.1038/nn.2575.
25. Askanas V, Engel WK, Nogalska A. 2009. Inclusion body myositis: a degenerative muscle disease associated with intra-muscle fiber multiprotein aggregates, proteasome inhibition, endoplasmic reticulum stress and decreased lysosomal degradation. Brain Pathol. 19:493-506. http://dx.doi.org/10.1111/j.1750-3639.2009.00290.x.
26. Askanas V, Engel WK. 2008. Inclusion-body myositis: muscle-fiber molecular pathology and possible pathogenic significance of its similarity to Alzheimer's and Parkinson's disease brains. Acta Neuropathol. 116:583-595. http://dx.doi.org/10.1007/s00401-008-0449-0.
27. Tresse E, Salomons FA, Vesa J, Bott LC, Kimonis V, Yao TP, Dantuma NP, Taylor JP. 2010. VCP/p97 is essential for maturation of ubiquitincontaining autophagosomes and this function is impaired by mutations that cause IBMPFD. Autophagy 6:217-227. http://dx.doi.org/10.4161/auto.6.2.11014.
28. Ju JS, Fuentealba RA, Miller SE, Jackson E, Piwnica-Worms D, Baloh RH, Weihl CC. 2009. Valosin-containing protein (VCP) is required for autophagy and is disrupted in VCP disease. J. Cell Biol. 187:875-888. http://dx.doi.org/10.1083/jcb.200908115.
29. Walter P, Ron D. 2011. The unfolded protein response: from stress pathway to homeostatic regulation. Science 334:1081-1086. http://dx.doi.org/10.1126/science.1209038.
30. Moreno JA, Radford H, Peretti D, Steinert JR, Verity N, Martin MG, Halliday M, Morgan J, Dinsdale D, Ortori CA, Barrett DA, Tsaytler P, Bertolotti A, Willis AE, Bushell M, Mallucci GR. 2012. Sustained translational repression by eIF2α-P mediates prion neurodegeneration. Nature 485:507-511. http://dx.doi.org/10.1038/nature11058.
31. Deriziotis P, Andre R, Smith DM, Goold R, Kinghorn KJ, Kristiansen M, Nathan JA, Rosenzweig R, Krutauz D, Glickman MH, Collinge J, Goldberg AL, Tabrizi SJ. 2011. Misfolded PrP impairs the UPS by interaction with the 20S proteasome and inhibition of substrate entry.EMBOJ. 30:3065-3077. http://dx.doi.org/10.1038/emboj.2011.224.
32. Nunziante M, Ackermann K, Dietrich K, Wolf H, Gadtke L, Gilch S, Vorberg I, Groschup M, Schatzl HM. 2011. Proteasomal dysfunction and endoplasmic reticulum stress enhance trafficking of prion protein aggregates through the secretory pathway and increase accumulation of pathologic prion protein. J. Biol. Chem. 286:33942-33953. http://dx.doi.org/10.1074/jbc.M111.272617.
33. Fischer M, Rülicke T, Raeber A, Sailer A, Moser M, Oesch B, Brandner S, Aguzzi A, Weissmann C. 1996. Prion protein (PrP) with aminoproximal deletions restoring susceptibility of PrP knockout mice to scrapie. EMBO J. 15:1255-1264.
34. National Research Council. 2011. Guide for the care and use of laboratory animals, 8th ed. National Academies Press, Washington, DC.
35. Polymenidou M, Moos R, Scott M, Sigurdson C, Shi YZ, Yajima B, Hafner-Bratkovic I, Jerala R, Hornemann S, Wüthrich K, Bellon A, Vey M, Garen G, James MN, Kav N, Aguzzi A. 2008. The POM monoclonals: a comprehensive set of antibodies to non-overlapping prion protein epitopes. PLoS One 3:e3872. http://dx.doi.org/10.1371/journal.pone.0003872.
36. Hesse B, Fischer MS, Schilling N. 2010. Distribution pattern of muscle fiber types in the perivertebral musculature of two different sized species of mice. Anat. Rec. (Hoboken) 293:446-463. http://dx.doi.org/10.1002/ar.21090.
37. Weihl CC, Temiz P, Miller SE, Watts G, Smith C, Forman M, Hanson PI, Kimonis V, Pestronk A. 2008. TDP-43 accumulation in inclusion body myopathy muscle suggests a common pathogenic mechanism with frontotemporal dementia. J. Neurol. Neurosurg. Psychiatry 79:1186-1189. http://dx.doi.org/10.1136/jnnp.2007.131334.
38. Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, Bruce J, Schuck T, Grossman M, Clark CM, McCluskey LF, Miller BL, Masliah E, Mackenzie IR, Feldman H, Feiden W, Kretzschmar HA, Trojanowski JQ, Lee VM. 2006. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314:130-133. http://dx.doi.org/10.1126/science.1134108.
39. Salajegheh M, Pinkus JL, Taylor JP, Amato AA, Nazareno R, Baloh RH, Greenberg SA. 2009. Sarcoplasmic redistribution of nuclear TDP-43 in inclusion body myositis. Muscle Nerve 40:19-31. http://dx.doi.org/10.1002/mus.21386.
40. Isaacs AM, Powell C, Webb TE, Linehan JM, Collinge J, Brandner S. 2008. Lack of TAR-DNA binding protein-43 (TDP-43) pathology in human prion diseases. Neuropathol Appl. Neurobiol 34:446-456. http://dx.doi.org/10.1111/j.1365-2990.2008.00963.x.
41. Korth C, Stierli B, Streit P, Moser M, Schaller O, Fischer R, Schulz-Schaeffer W, Kretzschmar H, Raeber A, Braun U, Ehrensperger F, Hornemann S, Glockshuber R, Riek R, Billeter M, Wuthrich K, Oesch B. 1997. Prion (PrPSc)-specific epitope defined by a monoclonal antibody. Nature 390:74-77. http://dx.doi.org/10.1038/36337.
42. Kozutsumi Y, Segal M, Normington K, Gething MJ, Sambrook J. 1988. The presence of malfolded proteins in the endoplasmic reticulum signals the induction of glucose-regulated proteins. Nature 332:462-464. http://dx.doi.org/10.1038/332462a0.
43. Weihl CC, Miller SE, Hanson PI, Pestronk A. 2007. Transgenic expression of inclusion body myopathy associated mutant p97/VCP causes weakness and ubiquitinated protein inclusions in mice. Hum. Mol. Genet. 16:919-928. http://dx.doi.org/10.1093/hmg/ddm037.
44. Lin JH, Walter P, Yen TS. 2008. Endoplasmic reticulum stress in disease pathogenesis. Annu. Rev. Pathol. 3:399-425. http://dx.doi.org/10.1146/annurev.pathmechdis.3.121806.151434.
45. Rosen KM, Veereshwarayya V, Moussa CE, Fu Q, Goldberg MS, Schlossmacher MG, Shen J, Querfurth HW. 2006. Parkin protects against mitochondrial toxins and beta-amyloid accumulation in skeletal muscle cells. J. Biol. Chem. 281:12809-12816. http://dx.doi.org/10.1074/jbc.M512649200.
46. Page LJ, Suk JY, Bazhenova L, Fleming SM, Wood M, Jiang Y, Guo LT, Mizisin AP, Kisilevsky R, Shelton GD, Balch WE, Kelly JW. 2009. Secretion of amyloidogenic gelsolin progressively compromises protein homeostasis leading to the intracellular aggregation of proteins. Proc. Natl. Acad. Sci. U.S.A. 106:11125-11130. http://dx.doi.org/10.1073/pnas.0811753106.
47. Davies SW, Turmaine M, Cozens BA, DiFiglia M, Sharp AH, Ross CA, Scherzinger E, Wanker EE, Mangiarini L, Bates GP. 1997. Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell 90:537-548. http://dx.doi.org/10.1016/S0092-8674(00)80513-9.
48. Lin WL, Lewis J, Yen SH, Hutton M, Dickson DW. 2003. Filamentous tau in oligodendrocytes and astrocytes of transgenic mice expressing the human tau isoform with the P301L mutation. Am. J. Pathol. 162:213-218. http://dx.doi.org/10.1016/S0002-9440(10)63812-6.
49. Hipp MS, Patel CN, Bersuker K, Riley BE, Kaiser SE, Shaler TA, Brandeis M, Kopito RR. 2012. Indirect inhibition of 26S proteasome activity in a cellular model of Huntington's disease. J. Cell Biol. 196:573-587. http://dx.doi.org/10.1083/jcb.201110093.
50. Park C, Cuervo AM. 2013. Selective autophagy: talking with the UPS. Cell Biochem. Biophys. 67:3-13. http://dx.doi.org/10.1007/s12013-013-9623-7.
51. Kang R, Zeh HJ, Lotze MT, Tang D. 2011. The Beclin 1 network regulates autophagy and apoptosis. Cell Death Differ. 18:571-580. http://dx.doi.org/10.1038/cdd.2010.191.
52. Barth S, Glick D, Macleod KF. 2010. Autophagy: assays and artifacts. J. Pathol. 221:117-124. http://dx.doi.org/10.1002/path.2694.
53. Rubinsztein DC, Cuervo AM, Ravikumar B, Sarkar S, Korolchuk V, Kaushik S, Klionsky DJ. 2009. In search of an "autophagomometer." Autophagy 5:585-589. http://dx.doi.org/10.4161/auto.5.5.8823.
54. Florey O, Overholtzer M. 2012. Autophagy proteins in macroendocytic engulfment. Trends Cell Biol. 22:374-380. http://dx.doi.org/10.1016/j.tcb.2012.04.005.
55. Yedidia Y, Horonchik L, Tzaban S, Yanai A, Taraboulos A. 2001. Proteasomes and ubiquitin are involved in the turnover of the wild-type prion protein. EMBO J. 20:5383-5391. http://dx.doi.org/10.1093/emboj/20.19.5383.
56. Rane NS, Yonkovich JL, Hegde RS. 2004. Protection from cytosolic prion protein toxicity by modulation of protein translocation. EMBO J. 23:4550-4559. http://dx.doi.org/10.1038/sj.emboj.7600462.
57. Kitazawa M, Green KN, Caccamo A, LaFerla FM. 2006. Genetically augmenting Aβ42 levels in skeletal muscle exacerbates inclusion body myositis-like pathology and motor deficits in transgenic mice. Am. J. Pathol. 168:1986-1997. http://dx.doi.org/10.2353/ajpath.2006.051232.
58. Delaunay A, Bromberg KD, Hayashi Y, Mirabella M, Burch D, Kirkwood B, Serra C, Malicdan MC, Mizisin AP, Morosetti R, Broccolini A, Guo LT, Jones SN, Lira SA, Puri PL, Shelton GD, Ronai Z. 2008. The ER-bound RING finger protein 5 (RNF5/RMA1) causes degenerative myopathy in transgenic mice and is deregulated in inclusion body myositis. PLoS One 3:e1609. http://dx.doi.org/10.1371/journal.pone.0001609.
59. Nogalska A, D'Agostino C, Engel WK, Askanas V. 2011. Novel demonstration of conformationally modified tau in sporadic inclusion-body myositis muscle fibers. Neurosci. Lett. 503:229-233. http://dx.doi.org/10.1016/j.neulet.2011.08.042.
60. Brown AR, Rebus S, McKimmie CS, Robertson K, Williams A, Fazakerley JK. 2005. Gene expression profiling of the preclinical scrapieinfected hippocampus. Biochem. Biophys. Res. Commun. 334:86-95. http://dx.doi.org/10.1016/j.bbrc.2005.06.060.
61. Hetz C, Lee AH, Gonzalez-Romero D, Thielen P, Castilla J, Soto C, Glimcher LH. 2008. Unfolded protein response transcription factor XBP-1 does not influenceprionreplicationorpathogenesis. Proc. Natl.Acad.Sci.U.S.A.105:757-762.http://dx.doi.org/10.1073/pnas.0711094105.
62. Hetz C, Russelakis-Carneiro M, Maundrell K, Castilla J, Soto C. 2003. Caspase-12 and endoplasmic reticulum stress mediate neurotoxicity of pathological prion protein. EMBO J. 22:5435-5445. http://dx.doi.org/10.1093/emboj/cdg537.
63. Hetz C, Russelakis-Carneiro M, Walchli S, Carboni S, Vial-Knecht E, Maundrell K, Castilla J, Soto C. 2005. The disulfide isomerase Grp58 is a protective factor against prion neurotoxicity. J. Neurosci. 25:2793-2802. http://dx.doi.org/10.1523/JNEUROSCI.4090-04.2005.
64. Tang Y, Xiang W, Terry L, Kretzschmar HA, Windl O. 2010. Transcriptional analysis implicates endoplasmic reticulum stress in bovine spongiform encephalopathy. PLoS One 5:e14207. http://dx.doi.org/10.1371/journal.pone.0014207.
65. Moreno JA, Halliday M, Molloy C, Radford H, Verity N, Axten JM, Ortori CA, Willis AE, Fischer PM, Barrett DA, Mallucci GR. 2013. Oral treatment targeting the unfolded protein response prevents neurodegeneration and clinical disease in prion-infected mice. Sci. Transl. Med. 5:206ra138. http://dx.doi.org/10.1126/scitranslmed.3006767.
66. Hetz C, Castilla J, Soto C. 2007. Perturbation of endoplasmic reticulum homeostasis facilitates prion replication. J. Biol. Chem. 282:12725-12733. http://dx.doi.org/10.1074/jbc.M611909200.
67. Nogalska A, Terracciano C, D'Agostino C, King Engel W, Askanas V. 2009. p62/SQSTM1 is overexpressed and prominently accumulated in inclusions of sporadic inclusion-body myositis muscle fibers, and can help differentiating it from polymyositis and dermatomyositis. Acta Neuropathol.118:407-413. http://dx.doi.org/10.1007/s00401-009-0564-6.
68. Ju JS, Weihl CC. 2010. Inclusion body myopathy, Paget's disease of the bone and fronto-temporal dementia: a disorder of autophagy. Hum. Mol. Genet. 19:R38-R45. http://dx.doi.org/10.1093/hmg/ddq157.
69. Tannous P, Zhu H, Johnstone JL, Shelton JM, Rajasekaran NS, Benjamin IJ, Nguyen L, Gerard RD, Levine B, Rothermel BA, Hill JA. 2008. Autophagy is an adaptive response in desmin-related cardiomyopathy. Proc. Natl. Acad. Sci. U.S.A. 105:9745-9750. http://dx.doi.org/10.1073/pnas.0706802105.
70. Xu Y, Tian C, Wang SB, Xie WL, Guo Y, Zhang J, Shi Q, Chen C, Dong XP. 2012. Activation of the macroautophagic system in scrapie-infected experimental animals and human genetic prion diseases. Autophagy 8:1604-1620. http://dx.doi.org/10.4161/auto.21482.
71. Cortes CJ, Qin K, Cook J, Solanki A, Mastrianni JA. 2012. Rapamycin delays disease onset and prevents PrP plaque deposition in a mouse model of Gerstmann-Straussler-Scheinker disease. J. Neurosci. 32:12396-12405. http://dx.doi.org/10.1523/JNEUROSCI.6189-11.2012.
72. Aguib Y, Heiseke A, Gilch S, Riemer C, Baier M, Schatzl HM, Ertmer A. 2009. Autophagy induction by trehalose counteracts cellular prion infection. Autophagy 5:361-369. http://dx.doi.org/10.4161/auto.5.3.7662.
73. Heiseke A, Aguib Y, Riemer C, Baier M, Schatzl HM. 2009. Lithium induces clearance of protease resistant prion protein in prion-infected cells by induction of autophagy. J. Neurochem. 109:25-34. http://dx.doi.org/10.1111/j.1471-4159.2009.05906.x.